Please provide your email address to receive an email when new articles are posted on . Adding abiraterone acetate to androgen deprivation therapy plus docetaxel improved radiographic PFS and OS among ...

Lower-dose abiraterone demonstrated comparable efficacy to standard-dose abiraterone in select men with mCRPC. Lower-dose abiraterone acetate, 250 mg with low-fat food, is similarly effective to the ...

Please provide your email address to receive an email when new articles are posted on . Two years of abiraterone acetate plus prednisolone-based therapy significantly improved survival among men with ...

The FDA has approved niraparib and abiraterone acetate (Akeega, Janssen) plus prednisone for the treatment of certain patients with castration-sensitive prostate cancer (CSPC). Specifically, the ...

Clinical study design and research outcomes. (Bottom left) Low dose abiraterone acetate (AA) demonstrated reduced PSA levels-a marker of tumour activity. (Bottom middle) Safety profile suggested that ...

Among real-world US patients with mCSPC, apalutamide users achieved PSA90 response approximately 5 months earlier than abiraterone users, with more achieving deeper PSA decline. A real-world analysis ...